ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study

Wei, Sufang; Hu, Meixin; Chen, Hongjie; Xie, Qiuli; Wang, Peng; Li, Hong; Peng, Jie*南方医科大学
BMC GASTROENTEROLOGY2022-8-17DOI: 10.1186/s12876-022-02471-y
1被引9阅读
引用收藏
分享

摘要

Background There are inadequate data and no histological evidence regarding the effects of antiviral treatment for hepatitis B e-antigen (HBeAg)-negative chronic hepatitis B (CHB) patients with normal or mildly elevated alanine aminotransferase (ALT). This study investigated the effects of antiviral treatment on these patients. Methods We retrospectively analysed the outcomes of antiviral treatment for HBeAg-negative CHB patients with normal or mildly elevated ALT who were treated with nucleoside/nucleotide analogues (NAs) for up to 96 weeks. Results A total of 128 patients were enrolled; 74 patients had normal ALT and 54 patients had mildly elevated ALT. The total cumulative rates of viral suppression were 64.06%, 81.97%, and 96.39%, at weeks 24, 48, and 96, respectively. The cumulative rates of viral suppression for the normal and mildly elevated ALT groups were 67.85% and 58.97%, 86.39% and 76.31%, and 93.13% and 97.04% at weeks 24, 48, and 96, respectively. The serum HBV DNA levels at week 12 and hepatitis B surface antigen (HBsAg) levels at week 24 were significant predictors of the 96-week virological response. Of the 128 patients, 54 with normal ALT and 33 with mildly elevated ALT underwent FibroScan at baseline. Significant fibrosis (F >= 2) was found in 44.4% (n = 24) and 51.5% (n = 17) of the patients in the normal ALT group and mildly elevated ALT group, respectively. Compared with the values at baseline, liver stiffness values significantly decreased at week 48 (8.12 kPa vs. 6.57 kPa; p < 0.001) and week 96 (8.87 kPa vs. 6.43 kPa; p < 0.001), respectively. Conclusions HBeAg-negative CHB patients with normal ALT could benefit from antiviral therapy with NAs, similar to patients with mildly elevated ALT. Antiviral treatment is strongly recommended for HBeAg-negative CHB patients with normal ALT. Additionally, significant liver fibrosis is not rare in HBeAg-negative CHB patients with ALT less than two-times the upper limit of normal, and FibroScan should be performed regularly for these patients.

学科与关键词

关键词
Chronic hepatitis BHepatitis B virus DNAAlanine aminotransferaseNucleosidenucleotide analoguesFibroScan
相关
加载中…
  • Effective Analysis of Antiviral Treatment in Patients with HBeAg-Seropositive Chronic Hepatitis B with ALT < 2 Upper Limits of Normal: A Multi-center Retrospective Cohort Study
    Hu, Meixin; Liao, Guichan; Wei, Sufang; Qian, Zhe; Chen, Hongjie; Xia, Muye; Xie, Qiuli; Peng, Jie*Infectious Diseases and Therapy, 2023, 12(2): 637-647.
  • The Efficacy of Antiviral Treatment for Chronic Hepatitis B Patients with Normal ALT Levels: A Systematic Review and Meta-analysis
    Qian, Zhe; Hu, Meixin; Wu, Houji; Chen, Hongjie; Liao, Guichan; Kang, Zixin; Lin, Xiaoli; Peng, Jie*Hepatitis Monthly, 2022, 22(1): e129836.
  • Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg-positive chronic hepatitis B
    Tang, Yanhua; Fan, Rong; Lan, Zhixian; Xie, Qing; Zhang, Jiping; Liang, Xieer; Wang, Hao; Tan, Deming; Cheng, Jun; Chen, Shijun; Ning, Qin; Bai, Xuefan; Xu, Min; Chen, Xinyue; Niu, Junqi; Shi, Junping; Ren, Hong; Gao, Zhiliang; Wang, Maorong; Dou, Xiaoguang; Hou, Jinlin*; Sun, Jian*Journal of Medical Virology, 2023, 95(2).
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC GASTROENTEROLOGY
发表日期
2022-08-17
卷期
第 22 卷, 第 1 期
页码
387
DOI
10.1186/s12876-022-02471-y
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81971949]

作者

  • W

    Wei, Sufang (第一作者)

    southern med univ

  • H

    Hu, Meixin

    southern med univ

查看全部 7 位作者收起作者
  • C

    Chen, Hongjie

    southern med univ

  • X

    Xie, Qiuli

    southern med univ

  • W

    Wang, Peng

    southern med univ

  • L

    Li, Hong

    southern med univ

  • P

    Peng, Jie (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417